Khan Uqba, Hadid Tarik, Ibrar Warda, Sano Dahlia, Al-Katib Ayad
St. John Hospital and Medical Center, Detroit, MI, USA.
J Clin Med Res. 2017 Mar;9(3):213-215. doi: 10.14740/jocmr2929w. Epub 2017 Jan 25.
An 18-year-old African-American female presented with an episode of syncope. Initial investigations revealed large lung mass with invasion into right atrium along with lesions in kidneys and liver. Patient also developed superior vena cava syndrome due to lung mass. Biopsy of lung mass revealed diagnosis of composite lymphoma with involvement by primary mediastinal B-cell lymphoma (PMBCL) and classical Hodgkin lymphoma. Patient was started on dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH-R) with complete response to treatment. This case represents an extremely rare type of aggressive lymphoma and can guide clinicians in managing such cases since there are no standard guidelines for treatment. To the best of our knowledge, this is the first reported case of composite lymphoma of PMBCL and classical Hodgkin lymphoma successfully treated with dose-adjusted EPOCH-R regimen.
一名18岁非裔美国女性出现晕厥发作。初步检查发现肺部有巨大肿块,侵犯右心房,同时肾脏和肝脏有病变。患者还因肺部肿块出现上腔静脉综合征。肺部肿块活检显示诊断为复合性淋巴瘤,伴有原发性纵隔B细胞淋巴瘤(PMBCL)和经典型霍奇金淋巴瘤累及。患者开始接受剂量调整的依托泊苷、泼尼松、长春新碱、环磷酰胺、多柔比星和利妥昔单抗(EPOCH-R)治疗,治疗后完全缓解。该病例代表了一种极其罕见的侵袭性淋巴瘤类型,由于没有标准的治疗指南,可为临床医生处理此类病例提供指导。据我们所知,这是首例报道的采用剂量调整的EPOCH-R方案成功治疗的PMBCL和经典型霍奇金淋巴瘤复合性淋巴瘤病例。